Calycosin | Cyclosin | Plant Standard

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	20575-57-9
Formula :	C₁₆H₁₂O₅
M.W :	284.26
SMILES Code :	O=C1C(C2=CC=C(OC)C(O)=C2)=COC3=C1C=CC(O)=C3
Synonyms :	Cyclosin; 3'-Hydroxyformononetin
MDL No. :	MFCD00210598
InChI Key :	ZZAJQOPSWWVMBI-UHFFFAOYSA-N
Pubchem ID :	5280448

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P280-P305+P351+P338

B-CPAP cells	100 μM	12 days	Inhibited the colony formation of B-CPAP cells	PMC9800829
U251 cells	100 and 200 μM	18 hours	To evaluate the inhibitory effect of Calycosin on cell migration, results showed that 100 and 200 μM significantly reduced the number of migrating cells.	PMC5667511
U87 cells	100 and 200 μM	18 hours	To evaluate the inhibitory effect of Calycosin on cell migration, results showed that 100 and 200 μM significantly reduced the number of migrating cells.	PMC5667511
U251 cells	0-800 μM	24 hours	To evaluate the effect of Calycosin on cell proliferation, results showed that high concentrations (>400 μM) significantly inhibited cell proliferation.	PMC5667511
U87 cells	0-800 μM	24 hours	To evaluate the effect of Calycosin on cell proliferation, results showed that high concentrations (>400 μM) significantly inhibited cell proliferation.	PMC5667511
Rat thoracic aortic smooth muscle cell line A7r5	0-20 μM	24 hours	Calycosin inhibited vascular calcification by enhancing autophagic flux, reducing calcium nodule formation, decreasing calcium content and ALP activity, and suppressing the upregulation of RUNX2, BMP2, and OPN as well as the downregulation of SM22α.	PMC10781010
B-CPAP cells	100 μM	24 hours	Promoted the autophagy of B-CPAP cells	PMC9800829
B-CPAP cells	0, 25, 50, 100 μM	24 hours	Inhibited the proliferation of B-CPAP cells	PMC9800829
H9c2 cardiomyocytes	10 μM, 20 μM, 30 μM, 50 μM	24 hours	To evaluate the protective effect of Calycosin on doxorubicin-induced myocardial cell damage. Results showed that Calycosin significantly protected cells from damage at lower concentrations (10-30μM) while exhibiting cytotoxicity at higher concentrations (50 μM).	PMC11589554
HK-2 cells	8 μM, 16 μM, 32 μM	24 hours	To investigate the inhibitory effect of CAL on H/R-induced inflammatory response in HK-2 cells. Results showed that CAL dose-dependently reduced HIF-1α expression, inhibited the production of inflammatory cytokines (IL-1β, IL-6, TNF-α), and suppressed NF-κB activation.	PMC9585199
Bone marrow-derived macrophages (BMMs)	2.5, 5, 10 μM	3 days	To investigate the effect of Calycosin on RANKL-induced osteoclast differentiation. Results showed that Calycosin significantly inhibited RANKL-induced osteoclast formation in a dose-dependent manner.	PMC4691122
HCT116 cells	100 μM	48 hours	Calycosin suppressed TGF-β-induced EMT and migration by upregulating BATF2 expression.	PMC6555005
B16F10 melanoma cells	20, 40, 80 μM	48 hours	Evaluate the inhibitory effect of Calycosin on α-MSH-induced melanin synthesis and tyrosinase activity. Results showed that Calycosin significantly inhibited melanin synthesis and tyrosinase activity in a dose-dependent manner.	PMC8836186
HaCaT keratinocytes	10-100 μM	48 or 72 hours	Evaluate the effect of Calycosin on cell viability and determine the maximum concentration for future experiments. Results showed that cell viability remained above 80% after 48 or 72 hours.	PMC8836186
B16F10 melanoma cells	10-80 μM	48 or 72 hours	Evaluate the effect of Calycosin on cell viability and determine the maximum concentration for future experiments. Results showed that cell viability remained above 80% after 48 or 72 hours.	PMC8836186
LoVo cells	50, 100, 150 μM	6, 12, 24, 48 hours	Calycosin inhibited the proliferation of LoVo cells in a dose- and time-dependent manner. Significant inhibition was observed at 50 and 100 μM concentrations at 48 h, and at 150 μM concentration at 12 or 48 h (P<0.05).	PMC6555005

Mice	APP/PS1 transgenic Mice model	Intraperitoneal injection	10, 20, and 40 mg/kg	Daily for 70 days	Calycosin significantly improved cognitive function in APP/PS1 mice by activating the protein kinase C (PKC) pathway, reducing hippocampal levels of beta amyloid, Tau protein, interleukin-1beta, tumor necrosis factor-alpha, acetylcholinesterase, and malondialdehyde, while increasing acetylcholine and glutathione activities. These neuroprotective effects were abolished by the PKC inhibitor calphostin C.	PMC5745842
Drosophila melanogaster	Parkinson's disease model	Oral	100 µM	48 hours	Calycosin significantly improved the survival rate, locomotor function, reduced oxidative stress, protected dopaminergic neurons, and improved mitochondrial function and autophagy regulation in PQ-exposed Drosophila.	PMC8868496
Sprague-Dawley rats	Diabetic nephropathy model	Oral	30 mg/kg	4 weeks	To assess the regulatory effects of calycosin-loaded nanoliposomes on mitochondrial function in diabetic nephropathy rats	PMC8201677
Nude mice (BALB/c nu/nu)	U87 xenograft model	Intravenous injection	7.5 mg/kg	Every other day for 22 days	To evaluate the antitumor effect of Calycosin in vivo, results showed that Calycosin significantly reduced tumor volume and suppressed TGF-β and its downstream molecules.	PMC4769008
Rats	Drug metabolism model	Intragastric	25 mg/kg	Once daily for 8 days	To investigate the effect of Calycosin on the CYP450 system, results showed that Calycosin inhibits the catalytic activities of CYP1A2, CYP2D6 and CYP2C9	PMC6996205
Sprague-Dawley rats	MNNG-induced precancerous lesions of gastric carcinoma model	Oral	40 mg/kg, 80 mg/kg	Daily administration for 10 weeks	To evaluate the protective effect and mechanism of Calycosin on MNNG-induced precancerous lesions of gastric carcinoma. Results showed that Calycosin significantly ameliorated pathological changes in gastric mucosa, reduced intestinal metaplasia and dysplasia, and exerted protective effects by regulating the integrin β1/NF-κB/DARPP-32 pathway and suppressing STAT3 expression.	PMC7294567
Sprague-Dawley rats	Hind limb unloading (HLU) model	Intragastric administration	30 mg/kg	Once daily for 4 weeks	To investigate the potential protective effects of calycosin against bone loss induced by microgravity. Results showed that calycosin significantly increased bone mineral density (BMD), improved the microstructure of femoral trabecular bone, cortical bone thickness, and biomechanical properties of the bone. Analysis of bone turnover markers in serum indicated that both bone formation and resorption markers decreased after calycosin treatment. Additionally, bone remodeling-related cytokines (IFN-γ, IL-6, IL-8, IL-12, IL-4, IL-10, and TNF-α) in serum were partially restored after calycosin treatment.	PMC9259590
Wistar rats	Doxorubicin-induced heart failure model	Intraperitoneal injection	10 mg/kg	Once daily for four consecutive weeks	To evaluate the effect of Calycosin on cardiac function and myocardial injury in rats with heart failure. Results showed that Calycosin significantly improved cardiac function, reduced serum NT-Pro BNP levels, and alleviated myocardial cell damage and fibrosis.	PMC11589554
C57BL/6 mice	Renal ischemia/reperfusion injury (IRI) model	Intragastric administration	5 mg/kg, 10 mg/kg, 20 mg/kg	Once daily for 7 days	To investigate the protective effect of CAL on renal IRI and its mechanism. Results showed that CAL dose-dependently alleviated renal injury, reduced serum creatinine and blood urea nitrogen levels, decreased renal tubular damage score, inhibited NF-κB-mediated inflammatory response, and acted through the PPARγ/EGR1 pathway.	PMC9585199

{[proInfo.proName]}

CAS No.: 20575-57-9

{[proInfo.proName]}

CAS No.: 20575-57-9

Alternative Products

Product Details of Calycosin

Safety of Calycosin

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	3.52mL 0.70mL 0.35mL	17.59mL 3.52mL 1.76mL	35.18mL 7.04mL 3.52mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed